THYROID CANCER AND PARATHYROID FOUNDATION INC (EIN 271450561) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

JAMES NORMAN MD

Phone

8139914300

Tax Period

2024-01-01 to 2024-12-31

THYROID CANCER AND PARATHYROID FOUNDATION INC, founded in 2009, is a small nonprofit in the Medical Research sector that reported $153K in total revenue in fiscal year 2024. Revenue surged 3256% from the prior year, signaling strong growth momentum. The organization ran a surplus of $126K, a strong 83% operating margin.

Mission

THE ORGANIZATION'S MISSION IS TO HELP THE PUBLIC UNDERSTAND THE DANGERS OF HIGH BLOOD CALCIUM, PARATHYROID TUMORS, HYPERPARATHYROIDISM, AND HYPOPARATHYROIDISM AND TO IMPROVE THE LIVES OF ALL PEOPLE AFFECTED BY THE VARIOUS FORMS OF PARATHYROID DISEASE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $152,551

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $152,551

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $20,000

Other Expenses $26,297

TOTAL EXPENSES $26,297

Year-over-Year Comparison

	2024	2023	Change
Revenue	$152,551	$4,546	+32.6%
Expenses	$26,297	$24,419	+0.1%
Net Income	$126,254	$-19,873	-7.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
GARY CLAYMAN MD	DIRECTOR	0.50	Director	$0	$0	$0
JAMES NORMAN MD	SEC & TREASU	0.50	Officer Director	$0	$0	$0
RASHMI ROY MD	DIRECTOR	0.50	Director	$0	$0	$0
TOBIAS CARLING MD	PRESIDENT	0.50	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$152,551	$26,297	$557,614	$126,254
2023	$4,546	$24,419	$431,360	$-19,873
2022	$162,114	$26,212	$451,233	$135,902
2021	$196,553	$38,326	$315,331	$158,227
2020	$13,606	$5,434	$157,104	$8,172
2019	$14,839	$11,955	$150,941	$2,884

THYROID CANCER AND PARATHYROID FOUNDATION INC